TNDM in the 13F filings
Tandem Diabetes Care Inc · CUSIP 875372203
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 23 Jan 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 5 listed it in both
- Shares listed
- 12,370,699
- combined, among listed positions
- Reported value
- $272m
- combined, at the quarter end
Among the 92 comparable managers: 13 buyers (opened or added shares) and 19 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,093,798.
Managers listing TNDM in Q4 2025
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Citadel Advisors LLCexisting position · 2,088,603 shares now+2,048,802
- Marshall Wace LLPnew position · 875,531 shares now+875,531
- Balyasny Asset Management LLCnew position · 262,788 shares now+262,788
- Arrowstreet Capital LPnew position · 135,753 shares now+135,753
- Tudor Investment Corpnew position · 108,063 shares now+108,063
Reductions
- Acadian Asset Management LLCexisting position · 392,763 shares now-525,960
- Freestone Grove Partners LPexisting position · 1,442,836 shares now-427,471
- Fidelity (FMR LLC)existing position · 672,647 shares now-197,476
- Schonfeld Strategic Advisors LLCexisting position · 14,590 shares now-128,265
- Millennium Management LLCexisting position · 583,573 shares now-122,329
New positions and exits
New (8)
Exited (3)
- Walleye Capital LLCwas $5.6m
- Moore Capital Management LPwas $2.7m
- Renaissance Technologies LLCwas $2.0m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 1 | $5.0m | n.a. | n.a. |
| Q2 2018 | 2 | $50m | n.a. | n.a. |
| Q3 2018 | 5 | $172m | n.a. | n.a. |
| Q4 2018 | 6 | $179m | n.a. | n.a. |
| Q1 2019 | 9 | $226m | n.a. | n.a. |
| Q2 2019 | 10 | $206m | n.a. | n.a. |
| Q3 2019 | 7 | $259m | n.a. | n.a. |
| Q4 2019 | 4 | $232m | n.a. | n.a. |
| Q1 2020 | 9 | $944m | n.a. | n.a. |
| Q2 2020 | 10 | $1.7bn | n.a. | n.a. |
| Q3 2020 | 13 | $1.7bn | n.a. | n.a. |
| Q4 2020 | 6 | $1.1bn | n.a. | n.a. |
| Q1 2021 | 9 | $943m | n.a. | n.a. |
| Q2 2021 | 10 | $1.1bn | n.a. | n.a. |
| Q3 2021 | 13 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 16 | $1.9bn | n.a. | n.a. |
| Q1 2022 | 13 | $1.4bn | n.a. | n.a. |
| Q2 2022 | 10 | $740m | n.a. | n.a. |
| Q3 2022 | 8 | $748m | n.a. | n.a. |
| Q4 2022 | 11 | $836m | n.a. | n.a. |
| Q1 2023 | 10 | $411m | n.a. | n.a. |
| Q2 2023 | 9 | $306m | n.a. | n.a. |
| Q3 2023 | 6 | $256m | n.a. | n.a. |
| Q4 2023 | 8 | $388m | 2 | 6 |
| Q1 2024 | 9 | $426m | 4 | 5 |
| Q2 2024 | 7 | $332m | 3 | 3 |
| Q3 2024 | 7 | $295m | 2 | 5 |
| Q4 2024 | 10 | $188m | 7 | 2 |
| Q1 2025 | 4 | $44m | 1 | 2 |
| Q2 2025 | 7 | $74m | 5 | 1 |
| Q3 2025 | 6 | $64m | 4 | 1 |
| Q4 2025 | 5 | $81m | 13 | 19 |
| Q1 2026 | 5 | $69m | 16 | 15 |
| Q2 2026 | 6 | $73m | 18 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TNDM and LLY →TNDM and JNJ →TNDM and VRTX →Choose a stock to compare with TNDM →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TNDM, latest filings →Back to the 13F Explorer →